Lv0
0 积分 2026-01-06 加入
Site‐Specific Modification of Virus‐Like Particles for Exogenous Tumor Antigen Display and Minimizing Preexisting Immunity
1个月前
已完结
Multifunctional Lipidated Protein Carrier with a Built-In Adjuvant as a Universal Vaccine Platform Potently Elevates Immunogenicity of Weak Antigens
1个月前
已完结
Recombinant MUC1-MBP fusion protein combined with CpG2006 vaccine induces antigen-specific CTL responses through cDC1-mediated cross-priming mainly regulated by type I IFN signaling in mice
1个月前
已完结
Chemoenzymatic liquid-phase synthesis and immunogenic assessment of tumor-associated complex MUC1 glycopeptide variants
1个月前
已完结
Strategies for Synthesizing and Enhancing the Immune Response of Cancer Vaccines Based on MUC1 Glycopeptide Antigens
1个月前
已完结
A self-adjuvanting anti-tumor nanoliposomal vaccine based on fluorine-substituted MUC1 glycopeptide
1个月前
已完结
Peptide-based drugs in immunotherapy: current advances and future prospects
2个月前
已完结
Alum Adjuvant and Built-in TLR7 Agonist Synergistically Enhance Anti-MUC1 Immune Responses for Cancer Vaccine
2个月前
已完结
Molecular alterations of muc1 and their therapeutic exploitation: Emerging opportunities in cancer therapy
2个月前
已关闭
MUC1: An emerging target in cancer treatment and diagnosis
2个月前
已完结
皖公网安备34019202002308
